• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国 COVID-19“居家护理”患者的方案和临床特征:一项回顾性队列研究。

Protocol and clinical characteristics of patients under 'at-home care' for COVID-19 in South Korea: a retrospective cohort study.

机构信息

Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, South Korea.

Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, South Korea

出版信息

BMJ Open. 2022 Jun 2;12(6):e061765. doi: 10.1136/bmjopen-2022-061765.

DOI:10.1136/bmjopen-2022-061765
PMID:35654461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9163004/
Abstract

OBJECTIVE

As the number of patients with COVID-19 increased, at-home care was introduced for the first time in South Korea. This study aimed to analyse the characteristics and outcomes of patients who were treated under at-home care.

DESIGN, SETTING AND PARTICIPANTS: This retrospective cohort study targeted patients under at-home care for COVID-19 in Yeongdeungpo-gu in Seoul, Korea, from 18 October 2021 to 12 December 2021. The public health centre selected eligible patients for at-home care and registered with our institution. Nurses monitored patients, and doctors decided to transfer healthcare facilities and release the quarantined patients according to their symptoms.

OUTCOME MEASURES

Patient characteristics during the course of at-home care.

RESULTS

A total of 1422 patients were enrolled and 9574 patient-days were managed. Most patients were aged ≥60 years (22.7% (n=323)), and 82.8% did not have underlying conditions. The median length of care for patients was 8 days (IQR: 5-10 days). During the study period, 986 (69.3%) patients were released from quarantine, 82 (5.8%) patients were transferred to facilities and 354 (24.9%) patients were still under at-home care at the end of the study period. The most common cause of transfer was sustained fever (n=30; 36.6%), followed by dyspnoea and desaturation (n=17; 20.7%). Factors associated with transfer were diabetes (OR: 3.591, 95% CI 1.488 to 8.665, p=0.004), pregnancy (OR: 5.839, 95% CI 1.035 to 32.935, p=0.046) and being presymptomatic at diagnosis (OR: 4.015, 95% CI 1.559 to 10.337, p=0.004).

CONCLUSIONS

There were no specific problems related to patient safety when operating at-home care. Patients with risk factors, such as diabetes, were more likely to be transferred to healthcare facilities. For safe at-home care, it is necessary to prepare for an appropriate response to the emergency.

摘要

目的

随着 COVID-19 患者人数的增加,韩国首次引入了居家护理。本研究旨在分析接受居家护理的患者的特征和结局。

设计、地点和参与者:本回顾性队列研究针对的是 2021 年 10 月 18 日至 12 月 12 日期间在韩国首尔永登浦区接受 COVID-19 居家护理的患者。公共卫生中心选择符合条件的患者进行居家护理,并向我们机构登记。护士监测患者,医生根据症状决定将医疗设施转移和释放隔离患者。

结局指标

居家护理过程中患者的特征。

结果

共纳入 1422 名患者,管理了 9574 患者天。大多数患者年龄≥60 岁(22.7%(n=323)),82.8%无基础疾病。患者护理的中位数为 8 天(IQR:5-10 天)。在研究期间,986 名(69.3%)患者解除隔离,82 名(5.8%)患者转至设施,354 名(24.9%)患者在研究结束时仍接受居家护理。转院的最常见原因是持续发热(n=30;36.6%),其次是呼吸困难和血氧饱和度降低(n=17;20.7%)。与转院相关的因素包括糖尿病(OR:3.591,95%CI 1.488 至 8.665,p=0.004)、妊娠(OR:5.839,95%CI 1.035 至 32.935,p=0.046)和诊断前无症状(OR:4.015,95%CI 1.559 至 10.337,p=0.004)。

结论

在实施居家护理时,没有与患者安全相关的特定问题。患有糖尿病等危险因素的患者更有可能被转至医疗机构。为了安全的居家护理,有必要为紧急情况做好适当的应对准备。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2f/9163004/a0933b0b3be4/bmjopen-2022-061765f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2f/9163004/a0933b0b3be4/bmjopen-2022-061765f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2f/9163004/a0933b0b3be4/bmjopen-2022-061765f01.jpg

相似文献

1
Protocol and clinical characteristics of patients under 'at-home care' for COVID-19 in South Korea: a retrospective cohort study.韩国 COVID-19“居家护理”患者的方案和临床特征:一项回顾性队列研究。
BMJ Open. 2022 Jun 2;12(6):e061765. doi: 10.1136/bmjopen-2022-061765.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen.新冠肺炎患者在急性护理环境下使用补充氧气后出院后的死亡率和再入院率。
JAMA Netw Open. 2021 Apr 1;4(4):e213990. doi: 10.1001/jamanetworkopen.2021.3990.
4
The Development and Operation of a Home Management System during the COVID-19 Pandemic: Experience of the Local Government Gyeonggi-do in Korea.《COVID-19 大流行期间家庭管理系统的开发与运作:韩国京畿道地方政府的经验》。
J Korean Med Sci. 2021 May 17;36(19):e134. doi: 10.3346/jkms.2021.36.e134.
5
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
6
Workload of Healthcare Workers During the COVID-19 Outbreak in Korea: A Nationwide Survey.韩国 COVID-19 疫情期间医护人员的工作量:一项全国性调查。
J Korean Med Sci. 2022 Feb 14;37(6):e49. doi: 10.3346/jkms.2022.37.e49.
7
Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.丹麦隔离住院患者在 COVID-19 大流行期间的远程连续血糖监测:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Nov 25;21(1):968. doi: 10.1186/s13063-020-04872-4.
8
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.恢复期血浆/甲磺酸卡莫司他用于早期SARS-CoV-2 Q-PCR阳性高危个体(RES-Q-HR):一项随机对照试验研究方案的结构化总结
Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0.
9
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
10
Analysis of Critical COVID-19 Cases Among Children in Korea.韩国儿童危重症 COVID-19 病例分析。
J Korean Med Sci. 2022 Jan 3;37(1):e13. doi: 10.3346/jkms.2022.37.e13.

引用本文的文献

1
COVID-19 Outbreak in Daegu City, Korea and Response to COVID-19: How Have We Dealt and What Are the Lessons?韩国大邱市的 COVID-19 疫情爆发及对 COVID-19 的应对:我们是如何应对的,有哪些经验教训?
J Korean Med Sci. 2022 Dec 26;37(50):e356. doi: 10.3346/jkms.2022.37.e356.

本文引用的文献

1
A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19.全面评估 COVID-19 患者疾病恶化的早期潜在风险因素。
Sci Rep. 2021 Apr 13;11(1):8062. doi: 10.1038/s41598-021-87413-6.
2
Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.中国发生重症 COVID-19 的危险因素:疾病监测数据分析。
Infect Dis Poverty. 2021 Apr 12;10(1):48. doi: 10.1186/s40249-021-00820-9.
3
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.
COVID-19 重症和死亡的人群风险因素:一项全球系统回顾和荟萃分析。
PLoS One. 2021 Mar 4;16(3):e0247461. doi: 10.1371/journal.pone.0247461. eCollection 2021.
4
Limited Benefit of Facility Isolation and the Rationale for Home Care in Children with Mild COVID-19.轻症 COVID-19 患儿的住院隔离获益有限,提倡居家护理。
J Korean Med Sci. 2021 Feb 1;36(5):e45. doi: 10.3346/jkms.2021.36.e45.
5
The Psychological Burden of COVID-19 Stigma: Evaluation of the Mental Health of Isolated Mild Condition COVID-19 Patients.新冠病毒污名化的心理负担:隔离轻症新冠病毒患者心理健康评估。
J Korean Med Sci. 2021 Jan 18;36(3):e33. doi: 10.3346/jkms.2021.36.e33.
6
Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.新型冠状病毒病(COVID-19)的流行病学、发病机制、临床病程和治疗的最新进展。
Int J Clin Pract. 2021 Apr;75(4):e13868. doi: 10.1111/ijcp.13868. Epub 2020 Dec 6.
7
Operation and Management of Seoul Metropolitan City Community Treatment Center for Mild Condition COVID-19 Patients.首尔市轻症 COVID-19 患者社区治疗中心的运营与管理。
J Korean Med Sci. 2020 Oct 19;35(40):e367. doi: 10.3346/jkms.2020.35.e367.
8
Emerging Success Against the COVID-19 Pandemic: Hospital Surge Capacity in Taiwan.对抗新冠疫情的新成效:台湾地区医院的应急扩容能力
Ann Emerg Med. 2020 Sep;76(3):374-376. doi: 10.1016/j.annemergmed.2020.05.001. Epub 2020 May 6.
9
Clinical Characteristics and Disease Progression in Early-Stage COVID-19 Patients in South Korea.韩国早期新冠病毒肺炎患者的临床特征与疾病进展
J Clin Med. 2020 Jun 23;9(6):1959. doi: 10.3390/jcm9061959.
10
Operating Protocols of a Community Treatment Center for Isolation of Patients with Coronavirus Disease, South Korea.韩国社区治疗中心对冠状病毒病患者进行隔离的操作方案。
Emerg Infect Dis. 2020 Oct;26(10):2329-2337. doi: 10.3201/eid2610.201460. Epub 2020 Jun 22.